Basic & Clinical Medicine ›› 2024, Vol. 44 ›› Issue (1): 108-113.doi: 10.16352/j.issn.1001-6325.2024.01.0108

• Mini Reviews • Previous Articles     Next Articles

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis

SUN Lijie1, HAO Dandan2*   

  1. 1. Department of General Surgery, the Affiliated Hospital of Chifeng College, Chifeng 024005;
    2. Department of Physiology, School of Basic Medical Science,Chifeng University, Chifeng 024000, China
  • Received:2023-05-15 Revised:2023-10-31 Online:2024-01-05 Published:2023-12-25
  • Contact: *:hdd2011yx@163.com

Abstract: Emerging evidence suggests that ferroptosis, an iron-dependent form of regulated cell death, plays a critical role in the genesis of liver fibrosis through inducing hepatic stellate cell (HSC) ferroptosis to inhibit liver fibrosis or inducing hepatic ferroptosis to potentiates liver fibrosis. Pharmacologically targeting at ferroptosis with its inducers can slow down the progression of liver fibrosis in vitro and in vivo model. This review suggests that pharmacological induction of HSC ferroptosis might be used as a potential novel targeted therapy for the treatment of liver fibrosis.

Key words: liver fibrosis, hepatic stellate cell, ferroptosis

CLC Number: